Evidence of Neutralizing Antibodies Indicating the Cure of Patients Infected with COVID-19 Within one Month of Infection
- Autores: Abdulateef Y.1, Ayad Z.2, Noaman H.3, Fadhel M.4, Taha M.5, Rafeeq F.6, Salih A.7
- 
							Afiliações: 
							- Medical Microbiology Department, Medical College/ University of Anbar, Rumadi, Iraq
- Medical Chemistry Department, College of Medicine / Ibn Sina University of Medical and Pharmaceutical Sciences, Baghdad, Iraq
- Department of Medicine, College of Medicine / University of Anbar, Rumadi, Iraq
- Medical Biotechnology, Lagash Laboratory, Baghdad, Iraq
- Medical Biochemistry, Lagash Land Laboratory, Baghdad, Iraq
- Department of Biology, Biology Lagash Land Laboratory, Baghdad, Iraq
- Pathological Analysis, Lagash Laboratory, Baghdad, Iraq
 
- Edição: Volume 22, Nº 4 (2024)
- Seção: Medicine
- URL: https://cardiosomatics.ru/2211-3525/article/view/642325
- DOI: https://doi.org/10.2174/0122113525284502240217161226
- ID: 642325
Citar
Texto integral
Resumo
Background:During COVID-19 pandemic a major conflict facing the clinician where to prove cure of the patients.
Aims:The idea of confirming curability is based on clinical evaluation of the symptoms, laboratory investigations, and specific IgM, IgG anti-SARS-CoV2 antibodies.
Patients and Methods:All patients had presented with clinical features of COVID-19 positive PCR attended private clinic doctors consultant in internal medicine and infectious diseases, they did investigations in Lagash land private medical laboratory in Baghdad investigated and screened for COVID-19 by S. ferritin, D-dimer, Complete blood picture and LDH. All were reevaluated in the first month of infection by clinical examination, retesting, and screening for COVID-19 IgM IgG later to prove cure or evidence of viral infection in PCR negative cases.
Results:All patients are of different ages with maximum years affected from adulthood till the age of one hundred years. Male were 170(54.3%) patients and females were 143 (45.7%) total 313 patients (100%). Most are moderate socioeconomic status, with a significant number having comorbidities.
Conclusion:SARS COVID-19 IgM, IgG levels can be used to confirm a cure of the infection
Palavras-chave
Sobre autores
Yasir Abdulateef
Medical Microbiology Department, Medical College/ University of Anbar, Rumadi, Iraq
														Email: info@benthamscience.net
				                					                																			                												                														
Zainab Ayad
Medical Chemistry Department,College of Medicine / Ibn Sina University of Medical and Pharmaceutical Sciences, Baghdad, Iraq
														Email: info@benthamscience.net
				                					                																			                												                														
Haitham Noaman
Department ofMedicine, College of Medicine / University of Anbar, Rumadi, Iraq
							Autor responsável pela correspondência
							Email: info@benthamscience.net
				                					                																			                												                														
Marwa Fadhel
Medical Biotechnology, Lagash Laboratory, Baghdad,Iraq
														Email: info@benthamscience.net
				                					                																			                												                														
Mahammad Taha
Medical Biochemistry, Lagash Land Laboratory, Baghdad, Iraq
														Email: info@benthamscience.net
				                					                																			                												                														
Fatima Rafeeq
Department of Biology, Biology LagashLand Laboratory, Baghdad, Iraq
														Email: info@benthamscience.net
				                					                																			                												                														
Ahmed Salih
Pathological Analysis, Lagash Laboratory, Baghdad, Iraq
														Email: info@benthamscience.net
				                					                																			                												                														
Arquivos suplementares
 
				
			 
						 
						 
						 
					 
						 
									 
  
  
  Enviar artigo por via de e-mail
			Enviar artigo por via de e-mail 